Lumexa Imaging Holdings, Inc.

Lumexa Imaging Holdings, Inc. (LMRI) priced its initial public offering on Dec 12, 2025 at $18.50 per share, within its $17.00–$20.00 range, raising $462.5M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $1.75B. Barclays was lead-left underwriter, joined by J.P. Morgan, Jefferies and Deutsche Bank and others. Sidley Austin advised the company and Ropes & Gray advised the underwriters.

Lumexa Imaging Holdings, Inc. is a national provider of diagnostic imaging services, operating 184 outpatient imaging centers across 13 states, including eight joint ventures with health systems, in retail settings with extended hours.

Status

IPO

Ticker

LMRI

Exchange

Nasdaq Global Select

Priced

Dec 12, 2025

IPO price

$18.50

Price range

$17.00–$20.00

Raised

$462.5M

Market cap at IPO price

$1.75B

First filed

Nov 17, 2025

Underwriters

Barclays, J.P. Morgan, Jefferies, Deutsche Bank, Wells Fargo, Leerink Partners, William Blair, Capital One, Fifth Third, Raymond James, Academy Securities and Loop Capital

Company counsel

Sidley Austin

Underwriters' counsel

Ropes & Gray

Sector

Healthcare

Country / state

NC

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.